HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunocytochemical analysis of blood lymphocytes in uveitis.

Abstract
We studied the surface expression of activation markers IL2-R, HLA-DR and CD45-RO on peripheral T-lymphocytes in two groups of patients (n = 26) with idiopathic uveoretinitis, compared with controls. Thirteen patients were analysed by alkaline phosphatase anti-alkaline phosphatase (APAAP) immunocytochemistry, which demonstrated a significant rise in expression of HLA-DR and IL2-R surface markers. Flow cytometric analysis was performed on a further 13 patients, which confirmed a significant rise in IL2-R expression in uveitis patients. Within this group systemic activation was confined to patients with idiopathic retinal vasculitis. Dual flow cytometry confirmed a CD4+,IL2--R+ T--lymphocyte phenotype. A further 4 patients with retinal vasculitis who had been treated with cyclosporin A demonstrated a 32% reduction in IL2-R expression over a 3-month period. Analysis of CD45-RO and CD5+ cells was found to be uninformative in this study. We have demonstrated activated peripheral lymphocytes in patients predominantly with retinal vasculitis, the significance of which is discussed.
AuthorsA D Dick, Y F Cheng, A T Purdie, J Liversidge, J V Forrester
JournalEye (London, England) (Eye (Lond)) Vol. 6 ( Pt 6) Pg. 643-7 ( 1992) ISSN: 0950-222X [Print] England
PMID1289145 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers
  • HLA-DR Antigens
  • Receptors, Interleukin-2
  • Cyclosporine
  • Leukocyte Common Antigens
Topics
  • Biomarkers (analysis)
  • Cyclosporine (therapeutic use)
  • Flow Cytometry
  • HLA-DR Antigens (analysis)
  • Humans
  • Immunoenzyme Techniques
  • Leukocyte Common Antigens (analysis)
  • Lymphocyte Activation (immunology)
  • Receptors, Interleukin-2 (analysis)
  • Retinal Vessels
  • Retinitis (drug therapy, immunology)
  • T-Lymphocytes (immunology)
  • Uveitis, Posterior (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: